Best Practices User Guides-Cessation in Tobacco

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Cessation in Tobacco Prevention and Control Acknowledgements This guide was produced for the Centers for Disease Control and Prevention by the Center for Public Health Systems Science at the Brown School at Washington University in St. Louis. Primary contributors: Stephanie Andersen, Laura Brossart, Amy Endrizal, Isaiah Zoschke, Rachel Hackett, Rebecca Ballard, Douglas Luke Input was provided by: Rob Adsit, Stephen Babb, Brian King, Michon Mabry, Catherine Saucedo, Anna Schecter, Karla S. Sneegas, Brenna VanFrank, Renee Wright Input for the case studies was provided by: Christin M. Kirchenbauer, Oklahoma State Department of Health Eric Finley, Oklahoma Hospital Association Dana McCants Derisier, Rhode Island Tobacco Control Program Other contributions: Photograph on page 14 courtesy of the California Department of Public Health Photographs on page 20 courtesy of Oklahoma Tobacco Settlement Endowment Trust Photograph on page 26 courtesy of the University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) Photographs on page 28 courtesy of Tobacco Free Florida Photograph on page 31 courtesy of the New York City Department of Health and Mental Hygiene Photograph on page 36 courtesy of ClearWay Minnesota Photograph on page 42 courtesy of the New York State Department of Health Photograph on page 49 courtesy of the Rhode Island Department of Health Table of Contents Guide to the Reader ...........................................................................1 Making the Case for Cessation .................................................................2 Brief History .................................................................................. 3 How To ....................................................................................... 4 Understanding Cessation Interventions ............................................... 4 Getting Started ....................................................................... 8 Promoting Health Systems Change .................................................. 11 Improving Cessation Coverage ....................................................... 20 Supporting State Quitlines ........................................................... 27 Reducing Tobacco-Related Disparities ............................................... 33 Evaluating Cessation Interventions .................................................. 38 Sustaining Cessation Interventions ................................................... 42 Providing Support ........................................................................... 45 Case Studies ................................................................................. 46 Case for Investment ......................................................................... 50 Resources ................................................................................... 52 References .................................................................................. 62 GUIDE TO THE READER Purpose Organization The Center for Public Health Systems Science at 8 Making the Case: A brief overview of why Washington University in St. Louis is developing a cessation interventions are an essential part of set of user guides funded by the Centers for Disease tobacco control efforts Control and Prevention (CDC), contract 200-2015- 87568, for the Best Practices for Comprehensive 8 Brief History: How cessation interventions have Tobacco Control Programs—2014 (Best Practices changed from treating individual smokers to 2014), an evidence-based tool to help states develop promoting quitting at the population level and sustain comprehensive tobacco control programs. 8 How to: Strategies to plan and carry out cessation The purpose of the user guides is to help tobacco interventions control staff and partners implement evidence-based 8 Providing Support: How tobacco control best practices by translating research into practical programs can support cessation efforts guidance. The guides focus on strategies (e.g., programs and interventions) that have shown strong or promising 8 Case Studies: Real-world examples of successful evidence of effectiveness. Recommendations in this cessation interventions guide are suggestions for programs helping people quit tobacco. Programs can follow these recommendations 8 Case for Investment: Information to raise according to their needs, goals, and capacity. In the awareness about the importance of cessation user guides, tobacco refers to the use of manufactured, interventions commercial tobacco products. 8 Resources: Publications, toolkits, and websites to help in planning efforts Content This user guide focuses on how comprehensive tobacco control programs can promote cessation through Best Practices for Comprehensive population-wide efforts. According to Best Practices Tobacco Control Programs–20141 2014, “encouraging and helping tobacco users to quit is the quickest approach to reducing tobacco-related Best Practices 2014 is an evidence-based disease, death, and healthcare costs.”1 Population- guide to help states plan, establish, and based interventions can dramatically increase access to evaluate comprehensive tobacco prevention proven cessation treatment and help more people quit and control programs. The report offers for good. This guide offers program staff and partners recommendations and evidence for five information on how to promote health systems change, essential components of effective programs: improve insurance coverage for cessation treatment, State and community interventions and support state quitlines. • • Mass-reach health communication Links to More Information interventions • Cessation interventions Each instance of italicized, bolded blue text in the guide indicates a link to an additional resource or a • Surveillance and evaluation page within the guide with more information. Website • Infrastructure, administration, and addresses for all of the blue resources noted throughout management the guide are also included in the Resources section. Cessation l 1 MAKING THE CASE Making the Case for Cessation Every year, more than 480,000 Americans die from smoking.2 Another 16 million Americans live with a serious disease caused by smoking.2 Helping people quit using tobacco is the quickest way to reduce the disease, death, and immense cost caused by tobacco use.1 Cessation interventions are an essential part of a comprehensive tobacco control program because they: 8 Improve health and save lives 8 Address other community health priorities Quitting tobacco is not easy, but it is possible. Smoking cessation can help address other Quitting improves smokers’ health almost community health priorities, such as mental health immediately. Within 20 minutes, blood pressure and substance use recovery outcomes, cancer and heart rate decrease.3 Within a year, the risk survival rates, and pregnancy and child health of heart attack drops sharply.4 In 2–5 years, the outcomes.12-16 It also helps people better control chance for stroke can fall to about the same as diabetes and lowers the risk for heart disease as a nonsmoker’s.5 Although quitting has health much as or more than other common treatments benefits at any age, people who quit smoking before like aspirin.5,17 age 40 avoid most of the risk of dying early from a smoking-related disease.6 8 Create a return on investment Helping people quit tobacco is a smart investment. 8 Maximize the impact of other effective tobacco Tobacco use is expensive—people who smoke control strategies cost nearly $6,000 more per year to employ than 18 Comprehensive smoke-free laws, tobacco product people who do not smoke. Excess costs include price increases, and hard-hitting media campaigns healthcare costs and lost productivity due to motivate people to try to quit using tobacco and absenteeism, smoking breaks, and lower on-the- 18 make it easier for them do so.1,7-9 Combining job productivity (presenteeism). In comparison, these efforts with cessation interventions can evidence-based cessation interventions cost only connect people who use tobacco to evidence- a few hundred to a few thousand dollars for each 19 based treatment and help them quit successfully, person who quits. The savings can add up quickly; maximizing the impact on cessation.1 Supporting lower healthcare costs can save employers money 20 people who want to quit can also pave the way for in less than two years. smooth implementation of tobacco control policies and interventions.10 8 Support state and national healthcare goals Changes in healthcare delivery and payment 8 Reduce tobacco-related disparities models are increasingly being implemented to Some adults who smoke are less likely to quit improve quality of care and population health successfully, including people with less education, outcomes, while reducing healthcare costs. those living below the poverty level, and those Cessation interventions support these goals by without health insurance.11 These disparities increasing access to and use of evidence-based may result from factors such as limited financial treatments, quit attempts, and successful cessation, resources, lack of health insurance, lack of which in turn increases patient satisfaction and information about cessation treatments, or living in reduces tobacco-related disease, death, and environments less supportive of quitting tobacco.1,11 healthcare costs.21-23 Because quitting smoking Cessation interventions help overcome these prevents and improves the prognosis for many barriers by increasing access to evidence-based
Recommended publications
  • CLINICAL TRIALS Safety and Immunogenicity of a Nicotine Conjugate Vaccine in Current Smokers

    CLINICAL TRIALS Safety and Immunogenicity of a Nicotine Conjugate Vaccine in Current Smokers

    CLINICAL TRIALS Safety and immunogenicity of a nicotine conjugate vaccine in current smokers Immunotherapy is a novel potential treatment for nicotine addiction. The aim of this study was to assess the safety and immunogenicity of a nicotine conjugate vaccine, NicVAX, and its effects on smoking behavior. were recruited for a noncessation treatment study and assigned to 1 of 3 doses of the (68 ؍ Smokers (N nicotine vaccine (50, 100, or 200 ␮g) or placebo. They were injected on days 0, 28, 56, and 182 and monitored for a period of 38 weeks. Results showed that the nicotine vaccine was safe and well tolerated. Vaccine immunogenicity was dose-related (P < .001), with the highest dose eliciting antibody concentrations within the anticipated range of efficacy. There was no evidence of compensatory smoking or precipitation of nicotine withdrawal with the nicotine vaccine. The 30-day abstinence rate was significantly different across with the highest rate of abstinence occurring with 200 ␮g. The nicotine vaccine appears ,(02. ؍ the 4 doses (P to be a promising medication for tobacco dependence. (Clin Pharmacol Ther 2005;78:456-67.) Dorothy K. Hatsukami, PhD, Stephen Rennard, MD, Douglas Jorenby, PhD, Michael Fiore, MD, MPH, Joseph Koopmeiners, Arjen de Vos, MD, PhD, Gary Horwith, MD, and Paul R. Pentel, MD Minneapolis, Minn, Omaha, Neb, Madison, Wis, and Rockville, Md Surveys show that, although about 41% of smokers apy, is about 25% on average.2 Moreover, these per- make a quit attempt each year, less than 5% of smokers centages most likely exaggerate the efficacy of are successful at remaining abstinent for 3 months to a intervention because these trials are typically composed year.1 Smokers seeking available behavioral and phar- of subjects who are highly motivated to quit and who macologic therapies can enhance successful quit rates are free of complicating diagnoses such as depression 2 by 2- to 3-fold over control conditions.
  • Are Smoking, Environmental Pollution, and Weather Conditions Risk Factors for COVID-19? José Miguel Chatkin1a, Irma Godoy2a

    Are Smoking, Environmental Pollution, and Weather Conditions Risk Factors for COVID-19? José Miguel Chatkin1a, Irma Godoy2a

    J Bras Pneumol. 2020;46(5):e20200183 https://dx.doi.org/10.36416/1806-3756/e20200183 REVIEW ARTICLE Are smoking, environmental pollution, and weather conditions risk factors for COVID-19? José Miguel Chatkin1a, Irma Godoy2a 1. Departamento de Medicina Interna ABSTRACT e Pneumologia, Escola de Medicina, Pontifícia Universidade Católica do Rio Coronavirus disease 2019 (COVID-19), caused by the highly contagious severe acute Grande do Sul, Porto Alegre (RS) Brasil. respiratory syndrome coronavirus 2 (SARS-CoV-2), is probably systemic, has a major 2. Disciplina de Pneumologia, respiratory component, and is transmitted by person-to-person contact, via airborne Departamento de Clínica Médica, droplets or aerosols. In the respiratory tract, the virus begins to replicate within cells, Faculdade de Medicina de Botucatu, after which the host starts shedding the virus. The individuals recognized as being at risk Universidade Estadual Paulista, Botucatu (SP) Brasil. for an unfavorable COVID-19 outcome are those > 60 years of age, those with chronic diseases such as diabetes mellitus, those with hypertension, and those with chronic lung Submitted: 20 April 2020. diseases, as well as those using chemotherapy, corticosteroids, or biological agents. Accepted: 27 May 2020. Some studies have suggested that infection with SARS-CoV-2 is associated with other Study carried out at the Escola de risk factors, such as smoking, external environmental pollution, and certain climatic Medicina, Pontifícia Universidade Católica conditions. The purpose of this narrative review was to perform a critical assessment of do Rio Grande do Sul, Porto Alegre (RS) the relationship between COVID-19 and these potential risk factors. and at the Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Keywords: Coronavirus infections; COVID-19; Air pollution; Smoking; Tobacco use Botucatu (SP) Brasil.
  • Trends in Cigarette Smoking Cessation in the United States

    Trends in Cigarette Smoking Cessation in the United States

    Tobacco Control 1993; 2 (suppl): S3-S16 S3 SESSION I TRENDS IN CESSATION Tob Control: first published as 10.1136/tc.2.suppl1.S4 on 1 January 1993. Downloaded from Introduction Saul Shiftman I'm happy to welcome you here on behalf of of the National Heart, Lung and Blood the Planning Committee. It's a pleasure to see Institute's Smoking Education Program, this actually happening after almost a year of whose job it is to translate findings from planning, and I'm looking forward to the next intervention research into community action day and a half. and education programmes; he was formerly We have 2454 days left until the year 2000, the director of smoking intervention with the at which point the national goals are to have a American Heart Association. smoking prevalence of 15%. We're now at Dr Ellen Gritz is a long-time colleague of roughly 25 %. Put another way, we are 81 % of mine, although I hesitate to remind her in the way to the year 2000 from 1964, the year of public that she and I first started working the first Surgeon General's report, and we together a little over 20 years ago in Los have cut smoking prevalence roughly by half. Angeles. She is certainly one of the leading So we're doing pretty well but still have a bit experts in smoking and smoking cessation, and further to go. has particular interests in smoking among In this morning's panel, we'll be discussing women and in special populations. where we're going and how we're going to get Our last panellist, Dr Patrick O'Malley is there in terms of smoking cessation.
  • Smoking Cessation: a Report of the Surgeon General – 2020

    Smoking Cessation: a Report of the Surgeon General – 2020

    A SUMMARY OF SMOKING CESSATION: A REPORT OF THE SURGEON GENERAL – 2020 Smoking Cessation – The Role of Healthcare Professionals and Health Systems Smoking in the U.S. Key Findings from the 2020 Since the first Surgeon General’s report on smoking and health was Surgeon General’s Report released in 1964, cigarette smoking among U.S. adults has declined from nearly 43% to a low of nearly 14% in 2018. Despite this progress, smoking ` Smoking cessation reduces risk for many adverse health remains the leading cause of preventable disease and death in the U.S. effects, including poor reproductive health outcomes, Additionally, smoking-related illnesses continue to cost the nation more cardiovascular diseases, chronic obstructive pulmonary than $300 billion every year. disease (COPD), and cancer. Quitting smoking is also beneficial to those who have been diagnosed with heart Smoking Cessation Saves Lives disease and COPD. ` More than three out of five U.S. adults who have ever and Money smoked cigarettes have quit. Although a majority of cigarette smokers make a quit attempt each year, less Tobacco dependence is a chronic, relapsing condition driven by than one-third use cessation medications approved addiction to nicotine. But cessation treatment can help people quit. by the U.S. Food and Drug Administration (FDA) or The 2020 Surgeon General’s Report highlights the latest evidence on the behavioral counseling to support quit attempts. benefits of smoking cessation. The evidence is clear – one of the most important actions people can take to improve their health is to quit ` Considerable disparities exist in the prevalence of smoking, no matter how old they are or how long they’ve been smoking.
  • Smoking Cessation for Persons with Mental Illnesses

    Smoking Cessation for Persons with Mental Illnesses

    Smoking Cessation for Persons with Mental Illnesses A Toolkit for Mental Health Providers Updated January 2009 Table of Contents Overview 1 Why Address This Issue? 1 2 Alarming Statistics 2 3 About this Toolkit: 2 Who is this toolkit for? How do I use this toolkit? 4 Provider Pull-Out: Quick Facts Tobacco Use and Mental Illness 1 Smoking and Mental Illness: 3 Biological Predispositions, Psychological Considerations, Social Considerations, Stigma 2 Specific Psychiatric and Co-occuring Mental Disorders: 4 Depression, Schizophrenia, Co-occuring Substance Abuse and Dependance, Other Psychiatric Disorders 3 Tobacco Industry Targeting 5 Assessment and Intervention Planning 1 Readiness to Quit and Stages of Change: 6 Stages of Change, The 5 A’s (Flowchart, Actions and Strategies), The 5 R’s (Addressing Tobacco Cessation for Tobacco User Unwilling to Quit) 2 Cultural Considerations: 12 Recommendations for Mental Health Clinicians, Resources 3 Example of a Clinic Screening 4 Example of a Quitline Referral Form 5 Provider Pull-Out: The 5A’s and 2A’s & R Models Smoking Cessation Treatment for Persons with Mental Illness 1 Key Findings 14 2 Components of Successful Intensive Intervention Programs 15 3 Behavioral Interventions for Smoking Cessation: 16 Overview, SANE program, More Elements of Successful Counseling 4 Prescribing Cessation Medications 18 5 Intervening with Specific Mental Disorders: 19 Depression, Schizophrenia, Bipolar Disorder, Anxiety Disorder, Substance Use Disorders 6 Peer-to-Peer Services 21 7 Smoke-Free Policies 22 8 Provider
  • Building Capacity for Smoking Cessation and Treatment of Tobacco

    Building Capacity for Smoking Cessation and Treatment of Tobacco

    BUILDING CAPACITY FOR SMOKING Chapter 5 CESSATION AND TREATMENT OF TOBACCO DEPENDENCE Future needs for capacity-building Considerable progress has been made in the provision of effective treatments for tobacco dependence, both behavioural and pharmacological. For many years, behavioural interventions were the only option. Although a combination of behavioural and pharmacological treatment produces the best outcomes, behavioural treatments alone can also be effective. It is critically important that a wide range of interventions be used both in general to support tobacco cessation and specifically to support those who wish to quit tobacco use even where medication is not available (Lando, 2002). Social support for quitting should be possible in all countries, even those with extremely limited resources (Lando, 2002). Success has proved possible from training lay facilitators to conduct group cessation clinics. Abstinence outcomes for those clinics compare favourably with outcomes obtained by doctoral students in counselling psychology. According to the United States Clinical Practice Guideline (United States Department of Health and Human Services, 2000), both social support as part of treatment (intra-treatment social support) and help in securing social support outside of treatment (extra-treatment social support) are especially effective in increasing quitting. All countries have lay persons who can provide informal social support for quitting and who can be trained to conduct more formal interventions. There would appear to be special challenges in countries where there are relatively few ex-smokers and where tobacco prevalence rates are high among health professionals (Lando, 2002). Ex-smokers can serve as role models in encouraging quitting, and can provide social support to individuals who are attempting to quit.
  • A Teen Smoking Cessation Initial Study in Wuhan, China

    A Teen Smoking Cessation Initial Study in Wuhan, China

    Addictive Behaviors 29 (2004) 1725–1733 Project EX — A teen smoking cessation initial study in Wuhan, China Hong Zhenga,*, Steve Sussmana, Xinguang Chena, Yuanhong Wangb, Jiang Xiab, Jie Gongb, Chunhong Liub, Jianguo Shanb, Jennifer Ungera, C. Anderson Johnsona aInstitute for Health Promotion and Disease Prevention Research, University of Southern California, USA bCenters for Disease Control and Prevention of Wuhan, PR China Abstract The increasing smoking prevalence in China indicates a need for effective smoking cessation programs, yet, to our knowledge, no studies have evaluated the effects of smoking cessation programs among Chinese adolescents. A group of 46 10th-grade-level cigarette smokers from two schools in Wuhan, China, were provided with Project EX, an eight-session school-based clinic smoking cessation program developed in the United States. Efforts of translation of the Project EX curriculum, verification of translation, curriculum modification, and cultural adaptation were made to adapt the curriculum to the local culture. The 46 smokers represented 71% of all the self-reported 30-day smokers among 622 10th graders at these two schools. Only one student dropped out from the clinic program. Four-month follow-up data indicated a 10.5% 30-day quit rate and a 14.3% 7-day quit rate. The students who did not quit smoking reported a 16% reduction in daily cigarette consumption at posttest and a 33% reduction at 4-month follow-up. Use of a 2 1/2-week prebaseline-to-baseline clinic assessment indicated a clinic cohort nonassisted quit rate of 3%. These data provided evidence that Project EX can be adapted in another country, such as China; can be very well received; and can lead to promising results on cessation.
  • Smoking Cessation Workbook

    Smoking Cessation Workbook

    My Smoking Cessation Workbook My Smoking Cessation Workbook Acknowledgements The provider manual HIV Provider Smoking Cessation Handbook and the accompanying My Smoking Cessation Workbook were developed by the HIV and Smoking Cessation (HASC) Working Group of the Veterans Affairs Clinical Public Health (CPH). The authors primary goal was to develop materials promoting smoking cessation interventions, based on published principles of evidence- and consensus-based clinical practice, for use by HIV-care providers treating HIV+ patients who smoke. With permission from Dr. Miles McFall and Dr. Andrew Saxon, several materials used in these publications were modified from smoking cessation workbooks they developed for providers of patients with post traumatic stress disorder as part of the Smoking Cessation Project of the Northwest Network Mental Illness Research, Education & Clinical Center of Excellence in Substance Abuse Treatment and Education at the VA Puget Sound Health Care System. The Public Health Service Clinical Practice Guideline (Fiore, 2000) and the treatment model described by Richard Brown (2003) provided the foundation for their work and therefore indirectly ours as well.1 Many thanks to Kim Hamlett-Berry, Director of the Office of Public Health Policy and Prevention of CPH, for supporting this project; Hannah-Cohen Blair and Michelle Allen, research assistants, for their help organizing materials; and Leah Stockett for editing the manual and the workbook. As well, the HASC Working Group: Ann Labriola, Pam Belperio, Maggie Chartier, Tim Chen, Linda Allen, Mai Vu, Hannah Cohen-Blair, Jane Burgess, Maggie Czarnogorski, Scott Johns, and Kim Hamlett-Berry. 1 Brown, R. A. (2003). Intensive behavioral treatment. In D.
  • Part III: Training for Primary Care Providers: Brief Tobacco Interventions; Part IV: Training for Future Trainers: Applying Adult Education Skills to Training

    Part III: Training for Primary Care Providers: Brief Tobacco Interventions; Part IV: Training for Future Trainers: Applying Adult Education Skills to Training

    WHO Library Cataloguing-in-Publication Data Strengthening health systems for treating tobacco dependence in primary care. Contents: Part I: Training for policy-makers: developing and implementing health systems policy to improve the delivery of brief tobacco interventions; Part II: Training for primary care service managers: planning and implementing system changes to support the delivery of brief tobacco interventions; Part III: Training for primary care providers: brief tobacco interventions; Part IV: Training for future trainers: applying adult education skills to training. 1.Tobacco use disorder - prevention and control. 2.Smoking - prevention and control. 3.Smoking cessation. 4.Primary health care. 5.Delivery of health care. 6.Capacity building. 7.Teaching materials. I.World Health Organization. ISBN 978 92 4 150541 3 (NLM classification: HD 9130.6) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
  • How Can I Quit Smoking? (PDF)

    How Can I Quit Smoking? (PDF)

    ANSWERS Lifestyle + Risk Reduction by heart Smoking How Can I Quit Smoking? Smoking harms almost every tissue and organ in the body, including your heart and blood vessels. Nicotine, one of the main chemicals in cigarettes, causes your heart to beat faster and your blood pressure to rise. Carbon monoxide from smoking also gets into the blood and robs your body of oxygen. Nonsmokers who are exposed to secondhand smoke are also harmed. If you smoke or vape, you have good reason to worry about its effect on your health and the health of your loved ones and others. Deciding to quit is a big step. Following through is just as important. Quitting tobacco and nicotine addiction isn’t easy, but others have done it, and you can, too. Is it too late to quit smoking or vaping? quit. Some are: It’s never too late to quit. Quitting smoking has both short- • Stopping all at once on your Quit Day. term and long-term benefits for lowering your cardiovascular • Cutting down the number of cigarettes per day or risk. No matter how much or how long you’ve smoked when how many times you vape until you stop completely. you quit, your risk of heart disease and stroke starts to drop. • Smoking only part of each cigarette. If you use this People who quit smoking generally live longer than people method, you need to count how many puffs you take who continue to smoke. from each cigarette and reduce the number every While you may crave tobacco or nicotine after quitting, most two to three days.
  • A Hidden Epidemic: Tobacco Use and Mental Illness

    A Hidden Epidemic: Tobacco Use and Mental Illness

    1724 Massachusetts Avenue, N.W., Washington, DC 20036 | T 202 454 5555 | F 202 454 5599 | legacyforhealth.org 80220_Cover.indd 3 6/21/11 9:03 AM 80220_Cover.indd 4 6/21/11 9:03 AM A Hidden Epidemic: Tobacco Use and Mental Illness June 2011 80220_book.indd 1 6/21/11 12:40 AM Legacy’s Commitment to Dissemination Legacy® is a national non-profit committed to helping Americans live longer, healthier lives. Its mission is to build a world where young people reject tobacco and anyone can quit. To further this mission, Legacy has engaged in a comprehensive dissemination effort to share lessons learned from the replicable, sustainable tobacco control projects that were implemented across the nation with the assistance of past Legacy funding. In response to the recent financial downturn and to maximize the impact of limited funds, Legacy has shifted its efforts to focus mostly on population-based strategies and suspended its competitive grant-making programs. Legacy no longer solicits or accepts competitive funding requests and all existing grants will be phased out by 2012. A Hidden Epidemic: Tobacco Use and Mental Illness is the tenth publication in Legacy’s dissemination series. This publication seeks to call attention to the issue of the high prevalence of tobacco use and nicotine dependence among people with mental illnesses and to highlight barriers to effective tobacco-cessation efforts to help people with mental illnesses quit. This publication also features examples of five projects that demonstrate how organizations across America are addressing tobacco-related disparities faced by people with mental illnesses.
  • My Tobacco Cessation Workbook

    My Tobacco Cessation Workbook

    My Tobacco Cessation Workbook A Resource for Veterans This page intentionally left blank. My Tobacco Cessation Workbook A Resource for Veterans Acknowledgements The provider manual Primary Care & Tobacco Cessation and the accompanying My Tobacco Cessation Workbook were developed by Julianne Himstreet, Pharm.D., BCPS. The author’s primary goal was to develop materials promoting tobacco cessation interventions, based on published principles of evidence- and consensus-based clinical practice, for use by primary care providers treating patients who use tobacco. With permission from the HIV and Smoking Cessation (HASC) Working Group, several materials used in the Primary Care & Tobacco Cessation provider manual were modified from HIV Provider Smoking Cessation Handbook. The U.S. Public Health Service Clinical Practice Guideline (Fiore, 2000) and the treatment model described by Richard Brown (2003) provided the foundation for their work and therefore indirectly ours as well.1 Many thanks to Kim Hamlett-Berry, Director of Tobacco & Health Policy in Clinical Public Health, Office of Public Health, for supporting this project and Leah Stockett for editing the manual and the workbook. In addition, much appreciation needs to be given to Dana Christofferson, Kim Hamlett-Berry, Pam Belperio, and Tim Chen for their editing and content contributions.1 1 Brown, R. A. (2003). Intensive behavioral treatment. In D. B. Abrams, R. Niaura, R. Brown, K. M. Emmons, M. G. Goldstein, & P. M. Monti, The tobacco dependence treatment handbook: A guide to best practices (pp. 118-177). New York, NY: Guilford Press. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G., Gritz, E.